丙型肝炎病毒阳性供体与阴性受体进行肝移植--在墨西哥可行吗？

IF 1.5 Q3 GASTROENTEROLOGY & HEPATOLOGY

Revista de Gastroenterologia de Mexico Pub Date : 2023-10-01 DOI:10.1016/j.rgmx.2023.08.004

J.A. Torres-Díaz , E.A. Jasso-Baltazar , L. Toapanta-Yanchapaxi , J. Aguirre-Valadez , L. Martínez-Matínez , A. Sánchez-Cedillo , D. Aguirre-Villarreal , I. García-Juárez

{"title":"丙型肝炎病毒阳性供体与阴性受体进行肝移植--在墨西哥可行吗？","authors":"J.A. Torres-Díaz , E.A. Jasso-Baltazar , L. Toapanta-Yanchapaxi , J. Aguirre-Valadez , L. Martínez-Matínez , A. Sánchez-Cedillo , D. Aguirre-Villarreal , I. García-Juárez","doi":"10.1016/j.rgmx.2023.08.004","DOIUrl":null,"url":null,"abstract":"<div><p>Hepatitis C virus (HCV) infection is a worldwide public health problem associated with significant morbidity and mortality. In the context of liver transplantation, the demand for organs continues to exceed the supply, prompting the consideration of using organs from HCV-positive donors in HCV-negative recipients. The introduction of direct-acting antivirals (DAAs), which have demonstrated great efficacy in eradicating the virus, has made transplantation of organs from donors with HCV infection possible. The present article provides a brief review of the current evidence on the use of organs from HCV-infected patients.</p></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0375090623000861/pdfft?md5=ee64c31be5982018c83c43f23f5d4cd8&pid=1-s2.0-S0375090623000861-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Donantes de virus de la hepatitis C positivo en receptores negativo para trasplante hepático. ¿Es posible en México?\",\"authors\":\"J.A. Torres-Díaz , E.A. Jasso-Baltazar , L. Toapanta-Yanchapaxi , J. Aguirre-Valadez , L. Martínez-Matínez , A. Sánchez-Cedillo , D. Aguirre-Villarreal , I. García-Juárez\",\"doi\":\"10.1016/j.rgmx.2023.08.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Hepatitis C virus (HCV) infection is a worldwide public health problem associated with significant morbidity and mortality. In the context of liver transplantation, the demand for organs continues to exceed the supply, prompting the consideration of using organs from HCV-positive donors in HCV-negative recipients. The introduction of direct-acting antivirals (DAAs), which have demonstrated great efficacy in eradicating the virus, has made transplantation of organs from donors with HCV infection possible. The present article provides a brief review of the current evidence on the use of organs from HCV-infected patients.</p></div>\",\"PeriodicalId\":51767,\"journal\":{\"name\":\"Revista de Gastroenterologia de Mexico\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0375090623000861/pdfft?md5=ee64c31be5982018c83c43f23f5d4cd8&pid=1-s2.0-S0375090623000861-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista de Gastroenterologia de Mexico\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0375090623000861\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de Gastroenterologia de Mexico","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0375090623000861","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

丙型肝炎病毒（HCV）感染是一个全球性的公共卫生问题，发病率和死亡率都很高。在肝脏移植方面，器官供不应求，促使人们考虑将 HCV 阳性捐献者的器官用于 HCV 阴性的受者。直接作用抗病毒药物（DAAs）在根除病毒方面已显示出巨大疗效，它的问世使HCV感染供体的器官移植成为可能。本文简要回顾了目前使用 HCV 感染者器官的证据。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Donantes de virus de la hepatitis C positivo en receptores negativo para trasplante hepático. ¿Es posible en México?

Hepatitis C virus (HCV) infection is a worldwide public health problem associated with significant morbidity and mortality. In the context of liver transplantation, the demand for organs continues to exceed the supply, prompting the consideration of using organs from HCV-positive donors in HCV-negative recipients. The introduction of direct-acting antivirals (DAAs), which have demonstrated great efficacy in eradicating the virus, has made transplantation of organs from donors with HCV infection possible. The present article provides a brief review of the current evidence on the use of organs from HCV-infected patients.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Revista de Gastroenterologia de Mexico GASTROENTEROLOGY & HEPATOLOGY-

CiteScore

1.60

自引率

12.50%

发文量

102

审稿时长

12 weeks

期刊介绍： La Revista de Gastroenterología de México es el órgano oficial de la Asociación Mexicana de Gastroenterología. Sus espacios están abiertos a los miembros de la Asociación como a todo miembro de la comunidad médica que manifieste interés por utilizar este foro para publicar sus trabajos, cumpliendo con las políticas editoriales que a continuación se mencionan. El objetivo principal de la Revista de Gastroenterología de México, es publicar trabajos originales del amplio campo de la gastroenterología, así como proporcionar información actualizada y relevante para el área de la especialidad y áreas afines. Los trabajos científicos incluyen las áreas de Gastroenterología clínica, endoscópica, quirúrgica y pediátrica.